We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Low Risk in Treating Previously Coiled Aneurysm

By HospiMedica International staff writers
Posted on 09 Nov 2009
The risks associated with treating a recurrent or residual brain aneurysm that was initially treated by endovascular coiling are low, according to a new study.

Researchers at the University of Cincinnati (UC; OH, USA), the State University of New York (Buffalo, USA), the University of Puerto Rico (San Juan), and other institutions prospectively collected data recorded for 311 patients with coiled intracranial aneurysms who underwent 352 retreatment procedures after angiographic or clinical recurrence of hemorrhage (after the initial coiling). More...
The results analyzed included procedural complications and procedure-related morbidity, classified as major or minor, and temporary (less than 30 days) or permanent (over 30 days).

The results showed that retreatment mortality was 0.85% per procedure and 0.96% per patient. Treatment-related rates were 0.32% per patient and 0.28% per procedure for permanent or temporary major disability; 1.29% for permanent minor disability (1.14% per procedure); and 1.61% for temporary minor disability (1.42% per procedure). The total risk for death or permanent major disability was 1.28% per patient and 1.13% per procedure. A potential bias in the study, according to the researchers, was that surgeons could have chosen not to perform retreatment procedures on patients whose recurrent or residual aneurysm was too dangerous. The study was published in the August 2009 issue of Neurosurgery.

"This quantitative evidence is important to patients and physicians because there is often more than one way to treat a brain aneurysm,” said lead author Andrew Ringer, M.D., an associate professor, and director of endovascular neurosurgery at UC. "Having an aneurysm coiled and avoiding a surgical procedure that requires opening the skull can be a very attractive option for patients. On the downside, coiling carries a higher rate of aneurysm recurrence than the standard surgical treatment."

Related Links:

University of Cincinnati
State University of New York
University of Puerto Rico



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.